• / Free eNewsletters & Magazine
  • / My Account
Home>bluebird bio Announces Pricing of Public Offering of Common Stock

bluebird bio Announces Pricing of Public Offering of Common Stock

3party Content

Wed, 28 Jun 2017

bluebird bio Announces Pricing of Public Offering of Common Stock bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage biotechnology company committed to developing potentially transformative gene therapies for severe genetic diseases and cancer, today announced the pricing of an underwritten public

©2017 Morningstar Advisor. All right reserved.